3KT.F KONTIGO CARE AB

Healthcare Health Care Technology Frankfurt Exchange
0.0678 EUR
Close of Nov 11, 2026
0.0202 0.1615
Market cap
EUR 2.39M
P/E
-
P/B
0.54x
ROE
-3.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 3KT.F undervalued?

Graham number

The Graham number of KONTIGO CARE AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

KONTIGO CARE AB fundamental analysis

No fundamental analysis for KONTIGO CARE AB yet.

KONTIGO CARE AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About KONTIGO CARE AB

Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Care, a digital healthcare platform for treatment and follow-up of addictive diseases; and Previct Safety for real-time digital drug testing. The company was incorporated in 2013 and is based in Uppsala, Sweden.

Full company profile